title: Melioidosis: a greater threat than previously suspected?
abstract: Research released in 2016 shows that the global burden of Burkholderia pseudomallei infection is probably much higher than previously suspected. Better testing and reporting are needed if we are to detect outbreaks and diminish deadly delays in treatment. Worldwide, researchers need support for vaccine development, particularly for public health vaccines to protect people and animals in endemic areas. Because melioidosis can infect so many species, collaboration and communication between human and veterinary medicine experts will be key to tracking, treating and preventing B. pseudomallei infections.
authors.affiliation: P.O. Box 254, Norwalk, OH 44857, United States. Electronic address: erinkelserus@gmail.com.
authors.forename: Erin Archer
authors.initials: EA
authors.lastname: Kelser
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000302:isolation & purification; D016957:Burkholderia pseudomallei / Q000302:isolation & purification*; D017281:Cost of Illness; D055808:Drug Discovery / Q000191:economics / Q000458:organization & administration; D014943:Global Health; D006801:Humans; D000070516:Intersectoral Collaboration; D008554:Melioidosis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy / Q000662:veterinary*
chemical_list: D001428:Bacterial Vaccines
keywords: Burkholderia; Melioidosis; One health; Pseudomallei; Sepsis; Veterinary